Gabapentin is not FDA-approved for any anxiety disorder, but it is widely prescribed off-label for anxiety and has shown real benefits in clinical studies. It falls into a gray zone: there’s enough evidence to support its use in certain situations, but not enough to make it a first-line treatment. Most psychiatrists and prescribing guidelines reserve it for patients who haven’t responded to standard anxiety medications.
What Gabapentin Is Approved For
Gabapentin has two FDA-approved uses: managing nerve pain after shingles (postherpetic neuralgia) in adults and serving as an add-on treatment for partial seizures in people with epilepsy. No anxiety disorder appears anywhere on its official label. This matters because it means the large-scale clinical trials typically required for approval haven’t been completed for anxiety, so much of what we know comes from smaller studies and off-label clinical experience.
Its close relative, pregabalin, does have regulatory approval for generalized anxiety disorder in some countries (the UK, for instance), which has fueled interest in whether gabapentin might work similarly. Both drugs share the same core mechanism, but pregabalin has a larger evidence base for anxiety specifically.
How It Works in the Brain
Despite its name sounding like GABA (the brain’s main calming neurotransmitter), gabapentin doesn’t actually bind to GABA receptors. It was originally designed to mimic GABA, but researchers discovered it works through a completely different pathway. Gabapentin attaches to a specific part of voltage-gated calcium channels in the nervous system, reducing the flow of calcium into nerve cells. Less calcium at those junctions means less release of excitatory chemical signals, particularly glutamate, which is involved in the “alarm” circuits that drive anxiety.
Gabapentin also appears to boost GABA production indirectly and increase the number of certain calming receptors on cell surfaces. These combined effects, dampening excitatory signals while gently enhancing inhibitory ones, likely explain why it can quiet anxious thinking and physical tension. One important detail: this process requires the drug to be taken up into cells and to build up over time. Gabapentin’s effects on calcium channel activity are not immediate. Studies show the inhibition kicks in after roughly 17 to 20 hours of exposure, not within the first few hours. This helps explain why it takes days to weeks to feel the full benefit.
Evidence for Generalized Anxiety
For generalized anxiety disorder, the evidence is thin but suggestive. No randomized controlled trials have been published comparing gabapentin to placebo specifically for GAD. What exists are case reports showing a clear dose-dependent pattern: anxiety symptoms dropped to low or absent levels at total daily doses of 900 mg or higher, while doses below 600 mg daily were associated with a return of severe anxiety. In one well-documented case, a patient remained in complete remission from anxiety symptoms as long as her dose stayed at or above 900 mg per day.
These are promising signals, but case reports are the weakest form of clinical evidence. Without controlled trials, it’s impossible to rule out placebo effects or other factors. Pregabalin, by comparison, has robust trial data for GAD, with meta-analyses showing it significantly outperforms placebo (a moderate effect size of -0.37 on standardized scales).
Evidence for Social Anxiety
The strongest anxiety-related evidence for gabapentin comes from a randomized, double-blind, placebo-controlled trial involving 69 patients with social anxiety disorder. Participants took gabapentin at flexible doses between 900 and 3,600 mg daily for 14 weeks. Compared to placebo, those on gabapentin showed statistically significant reductions in social anxiety symptoms on both clinician-rated and self-reported scales. The researchers concluded that gabapentin offered a favorable risk-benefit ratio for social anxiety, though they noted that further studies were needed to confirm the findings and explore dose-response patterns.
A broader meta-analysis published in Molecular Psychiatry pooled data across anxiety conditions and found a consistent, though not universal, benefit for gabapentinoids over placebo. Effect sizes ranged from small to large depending on the specific anxiety context. Both gabapentin and pregabalin significantly reduced preoperative anxiety in surgical patients, with gabapentin actually showing a larger effect size (-0.92) than pregabalin (-0.55) in that setting.
Where It Fits in Treatment
A joint position statement from the Royal College of Psychiatrists and the British Association for Psychopharmacology is direct: gabapentinoids should not be considered first-line treatments for anxiety disorders. The guidance recommends using them only after standard psychological treatments and first-line medications (typically SSRIs or SNRIs) have been tried and either failed or weren’t tolerated.
This positioning makes gabapentin a third- or fourth-line option for most patients. In practice, doctors often prescribe it when someone can’t take SSRIs due to side effects, when benzodiazepines pose too high a risk of dependence, or when a patient has overlapping conditions like nerve pain and anxiety. It fills a niche rather than serving as a go-to treatment.
How Long It Takes to Work
Gabapentin is not a fast-acting anxiety reliever in the way benzodiazepines are. Some people notice a calming effect within the first week, particularly for physical symptoms like muscle tension and restlessness. Full therapeutic effects for anxiety typically take two to four weeks to develop, as the drug gradually reshapes how calcium channels function at a cellular level. Dosing usually starts low, around 300 mg on the first evening, and is increased over several days to a target of three times daily.
Common Side Effects
The most frequently reported side effects are drowsiness, dizziness, and fatigue, particularly during the first week or two. Some people experience coordination problems, blurred vision, or weight gain. These effects tend to be dose-dependent, meaning they’re more likely at higher doses, and they often lessen as the body adjusts. Starting at a low dose and increasing gradually helps minimize early side effects.
Dependence and Stopping Safely
Gabapentin was long considered to have low addiction potential, but that view has shifted. Physical dependence can develop, particularly at higher doses or with prolonged use. Stopping abruptly can trigger withdrawal symptoms including rebound anxiety (often worse than the original anxiety), insomnia, nausea, and pain. The standard recommendation is to taper over at least seven days when discontinuing.
For people who have been on gabapentin for a long time or at high doses, the taper may need to be much slower. In one published case involving severe dependence, the full tapering process took 18 months, with dose reductions as small as 5 mg every one to two weeks toward the end. This is an extreme example, but it underscores that gabapentin is not a medication to stop on your own without a plan. If you’re considering discontinuing, work with your prescriber to establish a gradual schedule that matches your situation.